Skip to main content

Table 7 Associations between chemotherapy regimen and tpCR in different combined groups

From: Real-world data on neoadjuvant chemotherapy with dual-anti HER2 therapy in HER2 positive breast cancer

Combined group

Total

Stratification by tpCR

n = 353

No

Yes

P Value

ER + PR + HER2-positive

73

54

19

0.102

AC-TPH

 

9

4

 

TCbPH

 

34

15

 

TPH

 

11

0

 

ER + PR-HER2-positive

72

36

36

0.850

AC-TPH

 

4

3

 

TCbPH

 

27

29

 

TPH

 

5

4

 

ER-PR-HER2-positive

208

77

131

0.014

AC-TPH

 

7

10

 

TCbPH

 

30

78

 

TPH

 

40

43

 
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us